Sildenafil for enhanced performance at high attitude?

Annals of Internal Medicine

Volumn 141, Issue 3, 2004, Pages 233-235

  Rubin, Lewis J ^a   Naeije, Robert ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL;

ALTITUDE; EXERCISE TOLERANCE; HEART LEFT VENTRICLE FUNCTION; HEART OUTPUT; HEMODYNAMICS; HUMAN; HYPOBARISM; HYPOXIA; LUNG GAS EXCHANGE; LUNG VASOCONSTRICTION; MOUNTAINEERING; OXYGEN CONSUMPTION; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW;

EID: 3543071068     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-141-3-200408030-00016     Document Type: Review

References (16)

1. de Saussure HB. Voyages dans les Alpes. Fauche-Borel L, ed. Neuchatel, Switzerland: Imprimeur du Roi; 1796. Cited by Houston CS. In: Going Higher. Oxygen, Man and Mountains. 4th ed. Seattle: The Mountaineers; 1998.
2. Ward MP, Milledge JS, West JB. High Altitude Medicine and Physiology. 2nd ed. London: Chapman & Hall Medical; 1995:217-38.
3. Fulco CS, Rock PB, Cymerman A. Maximal and submaximal exercise performance at altitude. Aviar Space Environ Med. 1998;69:793-801. [PMID: 9715971]
4. Ghofrani HA, Reichenberger F, Kohstall MG, Mrosek EH, Seeger T, Olschewski H, et al. Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp. A randomized, double-blind, placebo-controlled crossover trial. Ann Intern Med. 2004;141:169-77.
5. Zhao L, Mason NA, Morrell NW, Kojonazarov B, Sadykov A, Maripov A, et al. Sildenafil inhibits hypoxia-induced pulmonary hypertension. Circulation. 2001;104:424-8. [PMID: 11468204]
6. Ghofrani HA, Schermuly RT, Rose F, Wiedemann R, Kohstall MG, Kreckel A, et al. Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2003;167:1139-41. [PMID: 12684251]
7. Ghofrani HA, Wiedemann R, Rose F, Schermuly RT, Olschewski H, Weissmann N, et al. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial. Lancet. 2002;360:895-900. [PMID: 12354470]
8. Michelakis ED, Tymchak W, Noga M, Webster L, Wu XC, Lien D, et al. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension. Circulation. 2003;108:2066-9. [PMID: 14568893]
9. Calbet JA, Boushel R, Radegran G, Sondergaard H, Wagner PD, Saltin B. Why is VO2 max after altitude acclimatization still reduced despite normalization of arterial O2 content? Am J Physiol Regul Integr Comp Physiol. 2003;284: R304-16. [PMID: 12388462]
10. Boushel R, Calbet JA, Radegran G, Sondergaard H, Wagner PD, Saltin B. Parasympathetic neural activity accounts for the lowering of exercise heart rate at high altitude. Circulation. 2001;104:1785-91. [PMID: 11591615]
11. Reeves JT, Groves BM, Sutton JR, Wagner PD, Cymerman A, Malconian MK, et al. Operation Everest II: preservation of cardiac function at extreme altitude. J Appl Physiol. 1987;63:531-9. [PMID: 3654411]
12. McQuillan BM, Picard MH, Leavitt M, Weyman AE. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation. 2001;104:2797-802. [PMID: 11733397]
13. Vachiery JL, McDonagh T, Moraine JJ, Berre J, Naeije R, Dargie H, et al. Doppler assessment of hypoxic pulmonary vasoconstriction and susceptibility to high altitude pulmonary oedema. Thorax. 1995;50:22-7. [PMID: 7886643]
14. Maggiorini M, Melot C, Pierre S, Pfeiffer F, Greve I, Sartori C, et al. High-altitude pulmonary edema is initially caused by an increase in capillary pressure. Circulation. 2001;103:2078-83. [PMID: 11319198]
15. Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation. 2001;104:429-35. [PMID: 11468205]
16. Boussuges A, Molenat F, Burnet H, Cauchy E, Gardette B, Sainty JM, et al. Operation Everest III (Comex '97): modifications ofcardiac function secondary to altitude-induced hypoxia. An echocardiographic and Doppler study. Am J Respir Crit Care Med. 2000;161:264-70. [PMID: 10619830]